Key result
Comorbid arterial hypertension and non-alcoholic fatty liver disease was associated with increased values of modifiable cardiovascular risk factors compared to either condition alone.
Why the study?
Are cardiovascular risk factors more severe in patients with comorbid arterial hypertension and NAFLD compared to those with isolated AH or NAFLD?
Observational (n=17,202)
No
Are cardiovascular risk factors more severe in patients with comorbid arterial hypertension and NAFLD compared to those with isolated AH or NAFLD?
Patients with comorbid arterial hypertension and NAFLD have a higher burden of modifiable cardiovascular risk factors compared to those with either condition alone, highlighting the need for targeted prevention.
Purpose of the study. To study frequency of occurrence and values ofparameters of the main risk factors for cardiovascular diseases in patients with hypertension in combination with non-alcoholic fatty liver disease. Material and methods. The analysis of 17,202 medical cards of patients (6,730 men, 10,472 women), which were examined and treated in the clinic of the Scientific Research Institute of Experimental and Clinical Medicine, Novosibirsk, was carried out. Of them - 3,087patients with arterial hypertension (AH), combined with non-alcoholic fatty liver disease (NAFLD) (main group); 13,384 patients with isolated arterial hypertension; 731 patients with NAFLD (comparison groups). According to the clinical and laboratory examination, the following risk factors were assessed: high blood pressure, obesity, elevated blood levels of total cholesterol, low-density lipoprotein cholesterol, triglycerides, glucose, uric acid, a low content of high-density lipoprotein cholesterol in the blood. Results. In patients with hypertension combined with NAFLD, in comparison with patients with isolated diseases, an increase in the values of the indices determining the main modifiable risk factors for cardiovascular diseases (hypertension, obesity, hyperglycemia, hypercholesterolemia, hyperuricemia) was revealed. Similar changes were detected in both men and women. Conclusion. An important role of risk factors for cardiovascular diseases, which together represent the clinical manifestations of the metabolic syndrome, has been identified in the development of comorbid pathology - AH and NAFLD. The data obtained indicate the need for differentiated, personified prevention and treatment of patients with this comorbid pathology with mandatory identification and correction of modifiable risk factors for cardiovascular diseases.
No takes yet. Share an insight, caveat, or question.
Sevostyanova et al. (2018) conducted an observational in Arterial hypertension and non-alcoholic fatty liver disease (n=17,202). Comorbid arterial hypertension and NAFLD vs. Isolated arterial hypertension or isolated NAFLD was evaluated on Values of indices determining main modifiable risk factors for cardiovascular diseases (high blood pressure, obesity, lipids, glucose, uric acid). Comorbid arterial hypertension and non-alcoholic fatty liver disease was associated with increased values of modifiable cardiovascular risk factors compared to either condition alone.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: